{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:49:59Z","timestamp":1791344999139,"version":"4.3.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ajhp\/zxag305","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:57:54Z","timestamp":1790164674000},"source":"Crossref","is-referenced-by-count":0,"title":["Executive summary of the 2026 ashp commission on goals: next-generation therapeutics: cell & gene therapy (cgt) and other ultra-high-cost drugs"],"prefix":"10.1093","author":[{"given":"Monica","family":"Mehta","sequence":"first","affiliation":[{"name":"Office of Practice Advancement, American Society of Health-System Pharmacists , Bethesda, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2026100622533552100_zxag305-B1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2146\/ajhp180672","article-title":"Executive summary of the meeting of the 2018 ASHP Commission on Goals: Focus on Opioids","volume":"76","author":"American Society of Health-System Pharmacists","year":"2019","journal-title":"Am J Health-Syst Pharm"},{"key":"2026100622533552100_zxag305-B2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/ajhp\/zxz205","article-title":"Executive summary of the 2019 ASHP Commission on Goals: impact of artificial intelligence on healthcare and pharmacy practice","volume":"76","author":"Hawkins","year":"2019","journal-title":"Am J Health-Syst Pharm"},{"key":"2026100622533552100_zxag305-B3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/ajhp\/zxaa395","article-title":"Executive summary of the meeting of the 2020 ASHP Commission on Goals: preparing the healthcare workforce for a digital future","volume":"78","author":"Hawkins","year":"2021","journal-title":"Am J Health-Syst Pharm"},{"key":"2026100622533552100_zxag305-B4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/ajhp\/zxac034","article-title":"Executive summary of the meeting of the 2021 ASHP Commission on Goals: Optimizing Medication Outcomes Through Telehealth","volume":"79","author":"Hawkins","year":"2022","journal-title":"Am J Health-Syst Pharm"},{"key":"2026100622533552100_zxag305-B5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/ajhp\/zxac216","article-title":"Executive summary of the meeting of the 2022 ASHP Commission on Goals: Optimizing Hospital at Home and Healthcare Transformation","volume":"79","author":"Hawkins","year":"2022","journal-title":"Am J Health-Syst Pharm"},{"key":"2026100622533552100_zxag305-B6","doi-asserted-by":"publisher","first-page":"15964","DOI":"10.1093\/ajhp\/zxad261","article-title":"Executive summary of the meeting of the 2023 ASHP Commission on Goals: Optimizing Medication Therapy Through Advanced Analytics and Data-Driven Healthcare","volume":"81","author":"Hawkins","year":"2024","journal-title":"Am J Health-Syst Pharm"},{"issue":"11","key":"2026100622533552100_zxag305-B7","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1093\/ajhp\/zxae324","article-title":"Executive summary of the 2024 ASHP Commission on Goals: primary care delivery transformation","volume":"81","author":"Hawkins","year":"2024","journal-title":"Am J Health-Syst Pharm"},{"issue":"7","key":"2026100622533552100_zxag305-B8","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1093\/ajhp\/zxaf309","article-title":"Executive summary of the 2025 ASHP Commission on Goals: Preparing for the Evolving Healthcare Landscape","volume":"83","author":"Mehta","year":"2026","journal-title":"Am J Health-Syst Pharm"},{"issue":"6","key":"2026100622533552100_zxag305-B9","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.ymthe.2025.05.006","article-title":"The landscape of cell and gene therapy today","volume":"33","author":"Barrett","year":"2025","journal-title":"Mol Ther"},{"issue":"1","key":"2026100622533552100_zxag305-B10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41434-025-00573-2","article-title":"Therapeutic in vivo genome editing: innovations and challenges in rAAV vector-based CRISPR delivery","volume":"33","author":"Gil","year":"2026","journal-title":"Gene Ther"},{"issue":"1","key":"2026100622533552100_zxag305-B11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"2026100622533552100_zxag305-B12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/ajhp\/zxaf310","article-title":"Pharmacy Futures: Summit on Advanced Therapeutics","volume":"83","author":"Pierce","year":"2026","journal-title":"Am J Health-Syst Pharm"},{"key":"2026100622533552100_zxag305-B13","volume-title":"2025 Cell and Gene Therapy Report: Advancing the Future of Medicine","author":"McKesson Corporation","year":"2025"},{"key":"2026100622533552100_zxag305-B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2026.01.002","article-title":"From vision to viability: developing infrastructure for cell and gene therapy programs","author":"Mahmoudjafari","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"2026100622533552100_zxag305-B15","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/s41591-025-03813-5","article-title":"Noncanonical and mortality-defining toxicities of CAR T cell therapy","volume":"31","author":"Rejeski","year":"2025","journal-title":"Nat Med"},{"key":"2026100622533552100_zxag305-B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103267","article-title":"Treatment-related adverse events of chimeric antigen receptor-T therapies for cancers in clinical trials: a systematic review and meta-analysis","author":"Zhu","journal-title":"EClinicalMedicine"},{"issue":"6","key":"2026100622533552100_zxag305-B17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jcyt.2024.03.007","article-title":"Filling the gap: the workforce of tomorrow for CGT manufacturing as the sector advances","volume":"26","author":"Hopewell","year":"2024","journal-title":"Cytotherapy"},{"key":"2026100622533552100_zxag305-B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.45603","article-title":"Virtual nursing and the future of workforce sustainability","author":"Khairat","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2026100622533552100_zxag305-B19","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1093\/ajhp\/zxaf119","article-title":"Pharmacy-directed coordination of gene and high-cost therapies","volume":"83","author":"Hale","year":"2026","journal-title":"Am J Health-Syst Pharm"},{"key":"2026100622533552100_zxag305-B20","author":"Foundation for the Accreditation of Cellular Therapy"},{"key":"2026100622533552100_zxag305-B21","author":"Association for the Advancement of Blood and Biotherapies"},{"key":"2026100622533552100_zxag305-B22","author":"Centers for Medicare & Medicaid Services"},{"issue":"18","key":"2026100622533552100_zxag305-B23","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1001\/jama.2025.16537","article-title":"The Cell and Gene Therapy Access Model","volume":"334","author":"Majerol","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"2026100622533552100_zxag305-B24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jtct.2026.03.007","article-title":"Gene therapy for sickle cell disease: practice recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy","volume":"32","author":"Sharma","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"2026100622533552100_zxag305-B25","author":"Centers for Medicare & Medicaid Services"},{"issue":"1","key":"2026100622533552100_zxag305-B26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ajh.21880","article-title":"Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research","volume":"86","author":"Treadwell","year":"2011","journal-title":"Am J Hematol"},{"issue":"10","key":"2026100622533552100_zxag305-B27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1056\/NEJMsr1715626","article-title":"Balancing safety and innovation for cell-based regenerative medicine","volume":"378","author":"Marks","year":"2018","journal-title":"N Engl J Med"},{"key":"2026100622533552100_zxag305-B28","author":"Center for International Blood and Marrow Transplant Research"},{"key":"2026100622533552100_zxag305-B29","author":"US Food and Drug Administration"},{"key":"2026100622533552100_zxag305-B30","author":"Collins"},{"issue":"10","key":"2026100622533552100_zxag305-B31","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.18553\/jmcp.2022.28.10.1138","article-title":"Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective","volume":"28","author":"Kaplan","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"issue":"23","key":"2026100622533552100_zxag305-B32","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1182\/bloodadvances.2024012982","article-title":"Point-of-care CAR T manufacturing solutions: can 1 model fit all?","volume":"8","author":"Urbano-Ispizua","year":"2024","journal-title":"Blood Adv"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag305\/71635403\/zxag305.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag305\/71635403\/zxag305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:53:43Z","timestamp":1791341623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article\/doi\/10.1093\/ajhp\/zxag305\/8870102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag305","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"zxag305"}}